Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
GM-2505 by Gilgamesh Pharmaceuticals for Major Depressive Disorder: Likelihood of Approval
GM-2505 is under clinical development by Gilgamesh Pharmaceuticals and currently in Phase II for Major Depressive Disorder. According to GlobalData,...
GM-2505 by Gilgamesh Pharmaceuticals for Anxiety Disorders: Likelihood of Approval
GM-2505 is under clinical development by Gilgamesh Pharmaceuticals and currently in Phase II for Anxiety Disorders. According to GlobalData, Phase...
GM-2505 by Gilgamesh Pharmaceuticals for Psychiatric Disorders: Likelihood of Approval
GM-2505 is under clinical development by Gilgamesh Pharmaceuticals and currently in Phase I for Psychiatric Disorders. According to GlobalData, Phase...